Rep. Alexandria Ocasio-Cortez (D., N.Y.) falsely claimed that her work in Congress fast-tracked the arrival of life-saving HIV drugs to the market, taking credit for a corporate decision made four years before she was elected to Congress.
Responding to President Trump’s criticism of House Democrats, the progressive congresswomanfabricateda personal achievement by claiming that she “took on Big Pharma” with “colleagues in hearings that brought PrEP generic a year early” in a tweet last week.
In fact, Gilead, the pharmaceutical company behind PrEP—a medication that can reduce the transmission risk of HIV by 99 percent—had reached an agreement back in 2014 to allow a generic version of the drug to come to market a year early. The company disclosed that agreement weeks before its CEO, Daniel O’Day, appeared before Congress in May.
Although Ocasio-Cortez asserted in her tweet that Trump has spent three years jailing kids and making corruption “the cause celebré,” the White House has taken steps toward broadening access to HIV medication. The administration announced on Tuesday that it willprovideHIV prevention drugs free-of-charge to all uninsured people as part of its planto reduce new HIV transmission by 90 percent over the next 10 years.
AOC continues to get caught in lies but it remains unclear if her constituents will hold her accountable.